Table of Contents
What changed
Revenue, which for this investment vehicle is principally dividend income from the portfolio, fell 20.2% to NZ$59.9m (FY20: NZ$75.1m). Despite that, PBT swung from a NZ$221.8m loss to a NZ$50.9m profit (+NZ$272.7m), and NPAT swung from a NZ$226.7m loss to a NZ$68.2m profit (+NZ$295.0m). The swing sits almost entirely in non-income components of the P&L — unrealised and realised gains on investments — with total equity rising NZ$815.6m (+45.9%) to NZ$2.6b, a far larger move than the stated earnings figure and consistent with a portfolio appreciation cycle. Operating cash flow improved 16.0% to NZ$51.5m, cash eased marginally to NZ$85.2m, and the fixed-term loan of NZ$100.0m was unchanged. A final dividend of 14.0p per share was declared, which together with the 5.0p interim already paid makes 19.0p ordinary for the full year, alongside a 10.0p special paid in January.
What matters
- The earnings swing is a capital, not income, story. Dividend income is down more than a fifth; the positive result is driven by revaluation of the portfolio. This is normal for a closed-end investment trust but means the FY21 headline tells a reader very little about the durability of distributable earnings.
- Dividend cover from recurring income has tightened. Stated revenue of NZ$59.9m supports the 19.0p ordinary dividend, but the gap between income and the declared distribution (including the 10.0p special) is now being bridged by reserves and realised gains rather than growth in underlying dividend flow.
- Leverage is static in absolute terms (NZ$100.0m borrowings, NZ$85.2m cash, implied net debt ~NZ$14.8m), but the equity base grew 45.9%, so gearing on NAV has fallen materially. That is a balance-sheet easing, but it is market-driven rather than a deleveraging action.
Expectations
No quantitative targets or forward work disclosures were provided, so this release cannot be measured against management guidance. The only shape context is HY21: first-half revenue of NZ$34.5m implies an H2 of NZ$25.4m (H1 = 57.6% of full year), so the dividend-income run-rate weakened into H2. More strikingly, HY21 NPAT was NZ$543.6m versus full-year NZ$68.2m, implying an H2 loss of roughly NZ$475.4m as portfolio marks reversed. Readers should not extrapolate either the H1 profit shape or the FY headline — both are dominated by mark-to-market movements rather than operating progression.
Quality of result
Use PBT, not NPAT, as the cleaner read: the effective tax rate shown moves from 2.2% to 23.2% and NPAT printing above PBT points to below-the-line items (including the tax repayment referenced in interim commentary) that distort the bottom line. Even on PBT, the result is low-quality in the sense that matters for an income-oriented holder: the recurring dividend-income line fell 20.2%, and the profit itself is sourced from investment revaluation. Operating cash flow of NZ$51.5m — broadly in line with cash dividend receipts — is the more durable anchor, and it is up only modestly. Trade and other receivables rose from ~NZ$10.7m to ~NZ$15.3m, lifting receivable days from 52 to 93; on an income-dividend book this is worth watching but is not material in absolute dollars.
Unresolved
- What portion of the NZ$272.7m PBT swing is realised versus unrealised, and how much of the H2 reversal (~NZ$475.4m NPAT decline versus H1) is already unwinding post balance date?
- Is the 19.0p ordinary plus 10.0p special distribution intended as a repeatable policy or a one-off return of capital given revenue per share is below the prior year?
- What drove the NZ$4.6m rise in trade and other receivables, and does it reflect timing of portfolio dividend receipts or a structural change?
- How does the FY21 total return compare to the MSCI Emerging Markets benchmark, which is the stated performance yardstick but was not quantified in the extracted data?
This briefing cannot assess investment performance against benchmark, portfolio composition or concentration, or NAV per share, none of which were supplied in the extraction.
Key metrics
| Metric | FY21 | FY20 | Change |
|---|---|---|---|
| Revenue | $59.9m | $75.1m | -20.2% ↓ |
| Net profit after tax | $68.2m | −$226.7m | +130.1% ↑ |
| Net cash inflow from operating activities | $51.5m | $44.4m | +16.0% ↑ |
| Final dividend per share | 14.0c | — | — |
| Profit before tax | $50.9m | −$221.8m | +123.0% ↑ |
| Total assets | $2.6b | $1.9b | +37.9% ↑ |
Analytical metrics
| Metric | FY21 | FY20 | Context |
|---|---|---|---|
| Effective tax rate | 23.2% | n/m (loss period) | prior loss period |
| Debtor days | 93.4 | 52.2 | +41.2 days |
| Trade debtors | $0.0m | $0.0m | +$0.0m |
| Net debt | $14.8m | $12.2m | +$2.6m |
| Gross borrowings | $100.0m | $100.0m | +$0.0m |
| Payout ratio vs NPAT | 48.9% | — | — |
| ROE (annualised) | 2.6% | -12.8% | Strengthening |
| HY21 share of FY21 revenue | 57.6% | — | Other half was 42.4% |
| HY21 share of FY21 NPAT | 796.9% | — | Other half was -696.9% |
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.